Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ravelcare Ltd has filed its quarterly utilisation statement for IPO funds under SEBI Regulation 32(1). The company confirms no formal deviation in fund usage. Total IPO proceeds were Rs 2410.20 lakhs, with only Rs 760.91 lakhs (31.6%) actually utilised as of March 31, 2026, leaving Rs 1649.29 lakhs unutilised. The manufacturing facility in Amravati remains completely untouched with Rs 780.60 lakhs parked in Kotak Bank term deposits. Marketing spend is at 30% of allocation (Rs 346.80 lakhs of Rs 1150 lakhs). General corporate purpose shows a slight overutilisation of Rs 18.20 lakhs. The filing has been reviewed by the Audit Committee and certified by statutory auditors Ratan Chandak & Co LLP.
The significant unutilised IPO corpus (68% still in bank accounts) and zero spend on the proposed Amravati manufacturing facility could raise concerns about execution delays or slow business ramp-up, though the company maintains no deviation in purpose.